AIP
IMGN

Ameritas Investment Partners’s Immunogen Inc IMGN Stock Holding History

Ameritas Investment Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,261
Closed -$719K – 3104
2023
Q4 		$719K Buy
24,261
+702
+3% +$14K 0.03% 697
2023
Q3 		$374K Buy
23,559
+3,517
+18% +$58.5K 0.02% 866
2023
Q2 		$378K Buy
20,042
+4,398
+28% +$51.9K 0.01% 851
2023
Q1 		$60.1K Hold
15,644
– – ﹤0.01% 1859
2022
Q4 		$72.9K Hold
15,644
– – ﹤0.01% 1810
2022
Q3 		$74K Hold
15,644
– – ﹤0.01% 1712
2022
Q2 		$70K Hold
15,644
– – ﹤0.01% 1756
2022
Q1 		$74K Hold
15,644
– – ﹤0.01% 1829
2021
Q4 		$116K Hold
15,644
– – ﹤0.01% 1594
2021
Q3 		$89K Hold
15,644
– – ﹤0.01% 1767
2021
Q2 		$103K Hold
15,644
– – ﹤0.01% 1707
2021
Q1 		$127K Buy
15,644
+925
+6% +$7.55K ﹤0.01% 1516
2020
Q4 		$95K Hold
14,719
– – ﹤0.01% 1613
2020
Q3 		$53K Hold
14,719
– – ﹤0.01% 1805
2020
Q2 		$68K Buy
14,719
+1,740
+13% +$7.4K ﹤0.01% 1661
2020
Q1 		$44K Buy
12,979
+1,168
+10% +$5.11K ﹤0.01% 1746
2019
Q4 		$60K Hold
11,811
– – ﹤0.01% 1816
2019
Q3 		$29K Hold
11,811
– – ﹤0.01% 2196
2019
Q2 		$26K Hold
11,811
– – ﹤0.01% 2304
2019
Q1 		$32K Hold
11,811
– – ﹤0.01% 2124
2018
Q4 		$57K Hold
11,811
– – ﹤0.01% 1733
2018
Q3 		$112K Buy
11,811
+1,127
+11% +$10.8K 0.01% 1488
2018
Q2 		$104K Buy
10,684
+2,771
+35% +$29.2K 0.01% 1530
2018
Q1 		$83K Hold
7,913
– – ﹤0.01% 1612
2017
Q4 		$51K Buy
7,913
+1,262
+19% +$7.78K ﹤0.01% 1921
2017
Q3 		$55K Hold
6,651
– – ﹤0.01% 1842
2017
Q2 		$47K Hold
6,651
– – ﹤0.01% 1945
2017
Q1 		$26K Buy
+6,651
New +$19.4K ﹤0.01% 2270

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameritas Investment Partners's IMGN Position: Q1 2024 in Review

Ameritas Investment Partners sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 24,261 shares — an estimated $719K sold.

Ameritas Investment Partners first reported a position in IMGN in Q1 2017 and held it in 28 quarters. The position peaked at $719K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Ameritas Investment Partners reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 24,261 Immunogen Inc shares in Q1 2024, an estimated $719K.
  • Ameritas Investment Partners first reported a position in Immunogen Inc in Q1 2017 and held it in 28 quarters.
  • Ameritas Investment Partners's Immunogen Inc position peaked at $719K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Ameritas Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.